Medtronic (NYSE:MDT) said today that its Activa line of deep-brain stimulators won FDA approval for conditional, full-body MRI scans, claiming the devices as the only examples allowed on the U.S. market for full-body MR imaging. The approval applies both to new Activa devices and to the roughly 43,000 U.S. patients already implanted with them, Fridley, Minn.-based […]
Medtronic
UW to lead expansion of Medtronic’s HeartRescue program
Medtronic (NYSE:MDT) said today that the University of Washington will lead a U.S. expansion of its HeartRescue program, which aims to improve survival rates for sudden cardiac arrest. Fridley, Minn.-based Medtronic launched HeartRescue in 2010 in 5 states, looking to train healthcare providers on resuscitation methods to boost the SCA survival rate, which has not moved […]
Patent board hands St. Jude Medical a win over patent troll
A U.S. patent board last week handed a win over a patent troll to St. Jude Medical (NYSE:STJ), ruling that several claims in a patent owned by Atlas IP LLC are unpatentable. Atlas, a so-called “non-practicing entity,” was pursuing infringement lawsuits against St. Jude, cross-town rival Medtronic (NYSE:MDT), Boston Scientific (NYSE:BSX) and Biotronik. In a Dec. 3 ruling, the U.S. Patent […]
Medtronic finally escapes Lenox MacLaren bone mill suit
A federal judge in Colorado dismissed an anti-trust lawsuit filed against Medtronic (NYSE:MDT) by bone mill maker Lenox MacLaren Surgical, ruling that Lenox failed to name the correct Medtronic subsidiary in the suit. Louisville, Colo.-based Lenox MacLaren 1st inked a distribution deal with Medtronic subsidiary Medtronic Sofamor Danek USA in 2000, hoping the pact would provide the scale to […]
Medtronic mulls sale of some Covidien assets
With 3 quarters of operations under its belt since the $50 billion acquisition of Covidien, Medtronic (NYSE:MDT) is evaluating whether to sell off some of the Covidien assets, CEO Omar Ishrak told analysts yesterday during a conference call. Ishrak said Covidien, which Medtronic calls its minimally invasive therapies group, has “a very clear and compelling vision for the future, […]
Report: TMVR at least 4 years from U.S. market
Transcatheter mitral valve replacements are at least 4 years out from hitting the U.S. market, despite the $2 billion recently dropped on companies developing the technology by some of the top names in medtech. Medtronic (NYSE:MDT), Abbott (NYSE:ABT), Edwards Lifesciences (NYSE:EW) and HeartWare International (NSDQ:HTWR) in recent months have spent a total of $2 billion to buy […]
Medtronic’s Q2 earnings beat estimates
Medtronic‘s (NYSE:MDT) fiscal 2nd-quarter earnings beat expectations as revenues met estimates, prompting the medical device leviathan to raise the low end of its profit forecast. Fridley, Minn.-based Medtronic posted profits of $520 million, or $1 per share, on sales of $7.06 billion for the 3 months ended Oct. 30. Compared with the same quarter last year, before […]
Diabetes: Medtronic taps Schein as exclusive U.S. distributor
Medtronic (NYSE:MDT) said today that it tapped Henry Schein (NSDQ:HSIC) to be its exclusive distributor for some Type II diabetes products in the U.S. Fridley, Minn.-based Medtronic said the Henry Schein Medical business will distribute the products to primary care physicians here, including its iPro2 Professional continuous glucose monitor and the i-Port Advance injection port. “Medtronic is committed […]
FDA: Class II recall for Medtronic’s InSync III pacemakers
A battery longevity issue prompted Medtronic this month warn doctors about some 96,787 of its InSync III pacemakers, an action the FDA labeled a Class II recall, although Medtronic said only about 22,000 of the devices are still active. The Fridley, Minn.-based medical device titan sent a letter to physicians dated November 2015, warning that a high […]
Danaher lures ex-Medtronic legal eagle Ellis for GC spot | Personnel Moves
Danaher (NYSE:DHR) said it lured Brian Ellis from Medtronic (NYSE:MDT) to be its new general counsel, replacing Jonathan Graham, who jumpoed ship for Amgen (NSDQ:AMGN) last May. Ellis was general counsel for Medtronic’s restorative therapies group, after stints as GC and chief compliance officer for monitoring solutions at GE Healthcare (NYSE:GE) “Brian brings a wealth of experience leading and […]
Supreme Court denies Covidien in $177m surgical shears spat with J&J’s Ethicon
The long-running patent infringement war between Medtronic’s (NYSE:MDT) Covidien subsidiary and Johnson & Johnson‘s (NYSE:JNJ) Ethicon Endo-Surgery unit over surgical shears appears to be over, after the U.S. Supreme Court today declined to review the case. Covidien in August asked the Supremes to hear its appeal of a December 2014 decision by the U.S. Court of Appeals for the Federal Circuit, which […]